What is ICANS?

What is cytokine release syndrome? #myelomaПодробнее

CAR-T Toxicities: CRS and ICANSПодробнее

Treating CRS and ICANS: current approaches and future outlooksПодробнее

What is Cytokine Release Syndrome or CRS?Подробнее

CAR T Side Effects ICANSПодробнее

What are the management strategies for CRS and ICANS in MM?Подробнее

CAR T-cell toxicity: CRS, ICANS and prolonged cytopeniasПодробнее

Cytokine Release Syndrome (CRS) and Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)Подробнее

Immune effector cell associated neurotoxicity syndrome ICANSПодробнее

Management of CRS and ICANS after CAR-T therapy for ALLПодробнее

Immune effector cell associated neurotoxicity syndrome ICANSПодробнее

Strategies to mitigate ICANS as a side effect of CAR T-cell therapyПодробнее

Nursing perspectives: a look at ICANS in CAR-TПодробнее

CAR T-cell toxicity: CRS, ICANS and prolonged cytopeniasПодробнее

Neuro Lecture: Neurotoxicities of CAR T cell and ICI with Dr Bianca SantomassoПодробнее

Investigating the co-occurrence of CRS and ICANS after CAR-T therapy & the need for novel therapiesПодробнее

ICANS/CRS Clinical PearlПодробнее

The potential impact of ICANS on long-term cognition in patients with DLBCL who have received CAR-TПодробнее

Strategies to minimize the occurrence of CRS and ICANS in patients treated with CAR-T therapyПодробнее